These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22519963)

  • 1. Discovery of a potent and selective GPR120 agonist.
    Shimpukade B; Hudson BD; Hovgaard CK; Milligan G; Ulven T
    J Med Chem; 2012 May; 55(9):4511-5. PubMed ID: 22519963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR120 agonism as a countermeasure against metabolic diseases.
    Cornall LM; Mathai ML; Hryciw DH; McAinch AJ
    Drug Discov Today; 2014 May; 19(5):670-9. PubMed ID: 24315954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR120 agonists for the treatment of diabetes: a patent review (2014 present).
    Zhang X; Macielag MJ
    Expert Opin Ther Pat; 2020 Oct; 30(10):729-742. PubMed ID: 32799609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism.
    Hudson BD; Shimpukade B; Mackenzie AE; Butcher AJ; Pediani JD; Christiansen E; Heathcote H; Tobin AB; Ulven T; Milligan G
    Mol Pharmacol; 2013 Nov; 84(5):710-25. PubMed ID: 23979972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and SAR of a novel series of heterocyclic phenylpropanoic acids as GPR120 agonists.
    Zhang X; Cai C; Winters M; Wells M; Wall M; Lanter J; Sui Z; Ma J; Novack A; Nashashibi I; Wang Y; Yan W; Suckow A; Hua H; Bell A; Haug P; Clapper W; Jenkinson C; Gunnet J; Leonard J; Murray WV
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3272-3278. PubMed ID: 28642104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties.
    Christiansen E; Urban C; Grundmann M; Due-Hansen ME; Hagesaether E; Schmidt J; Pardo L; Ullrich S; Kostenis E; Kassack M; Ulven T
    J Med Chem; 2011 Oct; 54(19):6691-703. PubMed ID: 21854074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel selective GPR120 agonists with potent anti-diabetic activity by hybrid design.
    Sheng R; Yang L; Zhang Y; Xing E; Shi R; Wen X; Wang H; Sun H
    Bioorg Med Chem Lett; 2018 Aug; 28(15):2599-2604. PubMed ID: 29980358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetes.
    Christiansen E; Urban C; Merten N; Liebscher K; Karlsen KK; Hamacher A; Spinrath A; Bond AD; Drewke C; Ullrich S; Kassack MU; Kostenis E; Ulven T
    J Med Chem; 2008 Nov; 51(22):7061-4. PubMed ID: 18947221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel GPR120 agonist TUG891 modulates fat taste perception and preference and activates tongue-brain-gut axis in mice.
    Murtaza B; Hichami A; Khan AS; Shimpukade B; Ulven T; Ozdener MH; Khan NA
    J Lipid Res; 2020 Feb; 61(2):133-142. PubMed ID: 31806728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a Potent Free Fatty Acid 1 Receptor Agonist with Low Lipophilicity, Low Polar Surface Area, and Robust in Vivo Efficacy.
    Hansen SV; Christiansen E; Urban C; Hudson BD; Stocker CJ; Due-Hansen ME; Wargent ET; Shimpukade B; Almeida R; Ejsing CS; Cawthorne MA; Kassack MU; Milligan G; Ulven T
    J Med Chem; 2016 Mar; 59(6):2841-6. PubMed ID: 26928019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists.
    Sasaki S; Kitamura S; Negoro N; Suzuki M; Tsujihata Y; Suzuki N; Santou T; Kanzaki N; Harada M; Tanaka Y; Kobayashi M; Tada N; Funami M; Tanaka T; Yamamoto Y; Fukatsu K; Yasuma T; Momose Y
    J Med Chem; 2011 Mar; 54(5):1365-78. PubMed ID: 21319751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist.
    Sparks SM; Aquino C; Banker P; Collins JL; Cowan D; Diaz C; Dock ST; Hertzog DL; Liang X; Swiger ED; Yuen J; Chen G; Jayawickreme C; Moncol D; Nystrom C; Rash V; Rimele T; Roller S; Ross S
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1278-1283. PubMed ID: 28148462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery.
    Carullo G; Mazzotta S; Vega-Holm M; Iglesias-Guerra F; Vega-Pérez JM; Aiello F; Brizzi A
    J Med Chem; 2021 Apr; 64(8):4312-4332. PubMed ID: 33843223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models.
    Takeuchi M; Hirasawa A; Hara T; Kimura I; Hirano T; Suzuki T; Miyata N; Awaji T; Ishiguro M; Tsujimoto G
    Br J Pharmacol; 2013 Apr; 168(7):1570-83. PubMed ID: 22639973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases.
    Christiansen E; Watterson KR; Stocker CJ; Sokol E; Jenkins L; Simon K; Grundmann M; Petersen RK; Wargent ET; Hudson BD; Kostenis E; Ejsing CS; Cawthorne MA; Milligan G; Ulven T
    Br J Nutr; 2015 Jun; 113(11):1677-88. PubMed ID: 25916176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1.
    Xiong Y; Swaminath G; Cao Q; Yang L; Guo Q; Salomonis H; Lu J; Houze JB; Dransfield PJ; Wang Y; Liu JJ; Wong S; Schwandner R; Steger F; Baribault H; Liu L; Coberly S; Miao L; Zhang J; Lin DC; Schwarz M
    Mol Cell Endocrinol; 2013 Apr; 369(1-2):119-29. PubMed ID: 23403053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1β and TNFα inhibit GPR120 (FFAR4) and stimulate GPR84 (EX33) and GPR41 (FFAR3) fatty acid receptor expression in human adipocytes: implications for the anti-inflammatory action of n-3 fatty acids.
    Muredda L; Kępczyńska MA; Zaibi MS; Alomar SY; Trayhurn P
    Arch Physiol Biochem; 2018 May; 124(2):97-108. PubMed ID: 28835131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor.
    Lin DC; Guo Q; Luo J; Zhang J; Nguyen K; Chen M; Tran T; Dransfield PJ; Brown SP; Houze J; Vimolratana M; Jiao XY; Wang Y; Birdsall NJ; Swaminath G
    Mol Pharmacol; 2012 Nov; 82(5):843-59. PubMed ID: 22859723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsaturated bond recognition leads to biased signal in a fatty acid receptor.
    Mao C; Xiao P; Tao XN; Qin J; He QT; Zhang C; Guo SC; Du YQ; Chen LN; Shen DD; Yang ZS; Zhang HQ; Huang SM; He YH; Cheng J; Zhong YN; Shang P; Chen J; Zhang DL; Wang QL; Liu MX; Li GY; Guo Y; Xu HE; Wang C; Zhang C; Feng S; Yu X; Zhang Y; Sun JP
    Science; 2023 Apr; 380(6640):eadd6220. PubMed ID: 36862765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel GPR120-selective agonist promotes insulin secretion and improves chronic inflammation.
    Yang L; Lei XT; Huang Q; Wang T; Sun HB; Wang HY
    Life Sci; 2021 Mar; 269():119029. PubMed ID: 33450256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.